Sarfraz Ahmed

Dr. Sarfraz Ahmed


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in Clinical & Molecular Biomedicine
Verified
Journal Article
Open access
PDF file
SASarfraz Ahmed
Sarfraz Ahmed
LTLalita Thangwal
Lalita Thangwal
KHKim Ji Hoe
Kim Ji Hoe
Dyskeratosis congenita (DC) is a rare hereditary telomere biology disorder characterized by bone marrow failure, nail dystrophy, mucosal leukoplakia, and abnormal skin pigmentation. Telomere shortening resulting from defects in telomere maintenance genes is a central pathogenic mechanism of the disease. TERF1-interacting nuclear factor 2 (TIN2), encoded by the TINF2 gene, is a critical component of the shelterin complex that safeguards telomere integrity by coordinating interactions among TRF1, TRF2, and TPP1/POT1. Heterozygous missense mutations in TINF2 are known to cause autosomal dominant dyskeratosis congenita type 3. In this study, a comprehensive in silico analysis was performed to identify deleterious and pathogenic non-synonymous single-nucleotide polymorphisms (nsSNPs) in the TIN2 protein. A total of 271 nsSNPs were subjected to sequence-based prediction tools (SIFT, PROVEAN, PolyPhen-2, Mutation Assessor, and SAAFEC-SEQ). Structure-based stability analyses of 134 variants located within the resolved crystal structure (PDB ID: 5XYF) were conducted using SDM2, DUET, mCSM, and MUpro. High-confidence deleterious and destabilizing mutations were further evaluated for disease association using PMut, PhD-SNP, and Rhapsody. Twelve missense mutations (A16D, V22G, V34G, L38P, V49G, R52P, R56G, E109G, F114S, L121P, Y139C, and L150P) were consistently predicted as pathogenic. Detailed structural characterization revealed significant alterations in protein stability, packing density, accessible surface area, aggregation propensity, and intermolecular noncovalent interactions. Most of these mutations showed increased aggregation tendency or reduced solubility, suggesting disruption of shelterin complex stability. This study provides structural and functional insights into pathogenic TINF2 variants and highlights potential molecular mechanisms underlying autosomal dominant dyskeratosis congenita.

Verified
Journal Article
Open access
PDF file
SASarfraz Ahmed
Sarfraz Ahmed
SISana Iram
Sana Iram
AAAmar Akash
Amar Akash
KKKwonyoung Kim
Kwonyoung Kim
JKJihoe Kim
Jihoe Kim
Tetranectin (TN), also known as C-type lectin domain family 3 member B (CLEC3B), is a secreted glycoprotein originally identified through its high-affinity interaction with plasminogen. Although initially linked to fibrinolysis, TN is now increasingly recognized as an extracellular regulator associated with matrix remodeling, bone development, tissue repair, and disease-related proteolytic processes. Dysregulated TN expression has been reported in a broad range of pathological conditions, including cancer, cardiovascular disease, inflammatory disorders, and neurodegenerative states. In this review, we summarize current knowledge of TN with emphasis on its molecular architecture, ligand-binding properties, trimeric organization, and regulatory mechanisms. We further discuss its context-dependent biological functions, with particular attention to how tissue-specific and compartment-specific TN patterns may influence disease progression and clinical interpretation, especially in oncology. In addition, we evaluate the evidence supporting TN as a diagnostic and prognostic biomarker and consider its emerging therapeutic relevance. Finally, we outline the major challenges that currently limit clinical translation and highlight key directions for future investigation.